257 related articles for article (PubMed ID: 25973085)
1. CD147 and MMP-9 expressions in type II/III adenocarcinoma of esophagogastric junction and their clinicopathological significances.
Huang L; Xu AM; Peng Q
Int J Clin Exp Pathol; 2015; 8(2):1929-37. PubMed ID: 25973085
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
[TBL] [Abstract][Full Text] [Related]
3. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.
Urabe M; Ushiku T; Shinozaki-Ushiku A; Iwasaki A; Yamazawa S; Yamashita H; Seto Y; Fukayama M
Cancer Med; 2018 Oct; 7(10):5145-5154. PubMed ID: 30239168
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of clinicopathological features and prognosis between adenocarcinoma of esophagogastric junction and adenocarcinoma of gastric antrum].
Zhu Z; Wang Y; Li F; Gao J; Han B; Wang R; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):149-155. PubMed ID: 30799537
[TBL] [Abstract][Full Text] [Related]
6. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
[TBL] [Abstract][Full Text] [Related]
7. Lymphatic vessel invasion as a prognostic factor in patients with primary resected adenocarcinomas of the esophagogastric junction.
von Rahden BH; Stein HJ; Feith M; Becker K; Siewert JR
J Clin Oncol; 2005 Feb; 23(4):874-9. PubMed ID: 15681533
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of TAZ and β-catenin expression in adenocarcinoma of the esophagogastric junction.
Sun L; Chen F; Shi W; Qi L; Zhao Z; Zhang J
Diagn Pathol; 2014 Jul; 9():125. PubMed ID: 25029906
[TBL] [Abstract][Full Text] [Related]
9. [Adenocarcinoma of the esophagogastric junction: prognostic factors and results of primary surgery].
Bösing NM; Heise JW; Goretzki PE; Sarbia M; Röher HD
Chirurg; 2004 Nov; 75(11):1088-97. PubMed ID: 15168031
[TBL] [Abstract][Full Text] [Related]
10. Extranodal metastasis is a powerful prognostic factor in patients with adenocarcinoma of the esophagogastric junction.
Zhang HD; Tang P; Duan XF; Chen CG; Ma Z; Gao YY; Zhang H; Yu ZT
J Surg Oncol; 2013 Dec; 108(8):542-9. PubMed ID: 24018956
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma of the esophagogastric junction in Japan.
Yamamoto M; Baba H; Egashira A; Oki E; Ikebe M; Kakeji Y; Maehara Y
Hepatogastroenterology; 2008; 55(81):103-7. PubMed ID: 18507087
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of EGFR as an Independent Prognostic Factor in Adenocarcinoma of the Esophagogastric Junction.
Aratani K; Komatsu S; Ichikawa D; Ohashi T; Miyamae M; Okajima W; Imamura T; Kiuchi J; Nishibeppu K; Kosuga T; Konishi H; Shiozaki A; Fujiwara H; Okamoto K; Tsuda H; Otsuji E
Anticancer Res; 2017 Jun; 37(6):3129-3135. PubMed ID: 28551654
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of
Knief J; Reddemann K; Lazar-Karsten P; Herhahn T; Petrova E; Wellner U; Thorns C
J Clin Pathol; 2017 Mar; 70(3):274-276. PubMed ID: 28011578
[No Abstract] [Full Text] [Related]
14. Clinical and prognostic features of E-cadherin in adenocarcinoma of the esophagogastric junction patients.
Hu K; Zheng QM; Wang YP; Zhao MM; Sun ZG
Eur J Cancer Prev; 2023 Mar; 32(2):119-125. PubMed ID: 36484275
[TBL] [Abstract][Full Text] [Related]
15. [Clinical outcomes of surgical patients with types II and III adenocarcinoma of esophagogastric junction].
Chen XF; Chen HN; Zhang B; Chen ZX; Hu JK; Wang F; Yang HX; Chen JP
Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 43(2):289-92. PubMed ID: 22650050
[TBL] [Abstract][Full Text] [Related]
16. [Expression and clinical significance of DAPK1 and CD147 in esophageal squamous cell carcinoma].
Wan Y; Wu XY
Zhonghua Zhong Liu Za Zhi; 2012 Jan; 34(1):44-8. PubMed ID: 22490855
[TBL] [Abstract][Full Text] [Related]
17. Expression of epidermal growth factor receptor in esophageal and esophagogastric junction adenocarcinomas: association with poor outcome.
Wang KL; Wu TT; Choi IS; Wang H; Resetkova E; Correa AM; Hofstetter WL; Swisher SG; Ajani JA; Rashid A; Albarracin CT
Cancer; 2007 Feb; 109(4):658-67. PubMed ID: 17211865
[TBL] [Abstract][Full Text] [Related]
18. Individualized surgical strategies for cancer of the esophagogastric junction.
Stein HJ; Feith M; Siewert JR
Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
[TBL] [Abstract][Full Text] [Related]
19. Is adenocarcinoma of the esophagogastric junction different between Japan and western countries? The incidence and clinicopathological features at a Japanese high-volume cancer center.
Hasegawa S; Yoshikawa T; Cho H; Tsuburaya A; Kobayashi O
World J Surg; 2009 Jan; 33(1):95-103. PubMed ID: 18958523
[TBL] [Abstract][Full Text] [Related]
20. Lymph node metastases of adenocarcinoma of the esophagus and esophagogastric junction.
Zhang X; Watson DI; Jamieson GG
Chin Med J (Engl); 2007 Dec; 120(24):2268-70. PubMed ID: 18167216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]